ArticleMethods in molecular biology (Clifton, N.J.)2026
Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
mRNA display enables the selection of peptide and protein ligands from libraries containing more than a trillion unique sequences. Identifying optimal target binders, however, requires extensive post-selection analysis and optimization, which is often more challenging than the selection itself. Here, we outline general strategies for analyzing mRNA display selections with the goal of advancing a small set of high-quality ligands for further study. We describe methods for sequencing and analyzing selection pools to identify potential binders, followed by experimental approaches to validate target binding and characterize ligand-target interactions. We present strategies for constructing second-generation libraries to improve initial hits, along with more specialized selection techniques for further improving binding affinity and/or protease resistance. Together, these methods provide a comprehensive strategy for post-selection analysis and the development of optimized ligands for downstream applications.
Indexed as
Identifiers
42400847What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.